FDA
approval
· 2018-10-24
FDA Approved: IRBESARTAN — Supplemental Application (NorthStar RxLLC)
Summary
The FDA approved a supplemental application for IRBESARTAN (irbesartan) submitted by NorthStar RxLLC.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for IRBESARTAN (IRBESARTAN)